CTIS.eu › Cities › France › Marseille
Marseille
France
1,485 total trials
664 recruiting
Filter these 1,485 trials by phase, condition, sponsor and more.
Open in Search →
2024-515185-13-00
5
2022-12-21
geographic atrophy
2023-508528-36-00
5
2022-12-16
Resected squamous cell carcinoma of the head and neck
2022-502078-17-00
4
2022-12-15
unresectable hepatocellular carcinoma
2024-513230-38-00
5
2022-12-15
Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peri
2023-505645-12-00
4
2022-11-28
Parkinson's Disease
2023-509876-40-00
4
2022-11-22
Multiple System Atrophy
2024-513262-19-00
5
2022-11-21
Thrombotic Thrombocytopenic Purpura
2024-513651-32-00
4
2022-11-10
Juvenile Dermatomyositis
2023-507748-35-00
1
2022-11-08
Acute Myeloid Leukemia
2024-512803-37-00
5
2022-10-05
Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
2023-507430-25-00
1
2022-10-03
Relapsed and/or refractory B-cell Non-Hodgkin lymphoma (R/R B-NHL) and
2024-516970-31-00
4
2022-10-02
Age-related macular degeneration
2024-516064-28-00
5
2022-09-27
Acute Graft Versus Host Disease
2024-517660-27-00
4
2022-09-22
Glioblastoma multiforme (GBM)
2024-510729-24-00
6
2022-09-01
Chronic Migrane, Migrane, Medication Overuse Headache
2023-509569-19-00
10
2022-08-10
venous thromboembolism (VTE)
2024-511069-12-00
5
2022-07-28
Sjögren’s Syndrome
2023-509835-26-00
4
2022-07-06
Huntington’s Disease
2023-508357-58-00
7
2022-07-04
Acute lymphocytic leukaemia- Acute myeloid leukaemia refractory - Myel
2023-508734-34-00
10
2022-06-30
Pulmonary Arterial Hypertension (PAH)
2023-505455-44-00
9
2022-06-29
Solid tumours
2024-514347-28-00
5
2022-06-02
Men and women over 18 years of age with renal failure renal failure st
2024-511706-23-00
4
2022-05-31
Focal segmental glomerulosclerosis
2024-513653-75-00
5
2022-05-30
Eosinophilic granulomatosis with polyangiitis (EGPA), formerly called
Showing 1,321–1,344 of 1,485 trials